4th Quarter - Report

ML STRATEGIES, LLC for ASTELLAS PHARMA US, INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$60,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Jan 15, 2009 $60,000 Replaced
4th Quarter - Amendment Jan 6, 2010 $60,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S. 2313 and H.R. 3697, The Strategies to Address Antimicrobial Resistyance (STAAR Act); S. 2278, The Community and Healthcare Associated Infections (CHAI) Reduction Act; H. Res. 988 and S. Res. 454 MRSA Awareness Month. S. 3560, Q1 Program Suplemental Funding Act of 2008, provisions regarding antibiotics.

LobbyistCovered position, as disclosed
DAVID LEITER —
JEREMY RABINOVITZ Chief of Staff - Congresswoman Lois Capps

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S.Res. 454 (110th), S. 3560 (110th), S. 2278 (110th), H.R. 3697 (110th), S. 2313 (110th), H.Res. 988 (110th)

Medicare/Medicaid MMM

Issues related to the implementation of Section 501 (c) of the 2005 Deficit Reduction Act; S. 1951 and H.R. 3700, The Fair Medicaid Drug Payment Act, Section 2 (b) Prior Authorization Programs; S. 1887 and H.R. 3061 Amending Title XVIII of the Social Security Act to ensure access to critical medications under Medicare Part D.

LobbyistCovered position, as disclosed
DAVID LEITER —
JEREMY RABINOVITZ Chief of Staff - Congresswoman Lois Capps

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3700 (110th), S. 1951 (110th), H.R. 3061 (110th), S. 1887 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.